We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Nuclea, IRCM Partner to Validate Mass Spec Diabetes Assays

News   Aug 12, 2015

 
Nuclea, IRCM Partner to Validate Mass Spec Diabetes Assays
 
 
Advertisement
 

RELATED ARTICLES

New Method Can Distinguish Cancer Stem Cells From Other Cells Based on Genetics

News

Cancer stem cells can replicate indefinitely, fuelling long-term cancer growth and driving relapse. Researchers have overcome the problem of cancer stem cells being difficult to isolate and study by creating a method that can be used to distinguish cancer stem cells, mature cancer cells and otherwise healthy stem cells based on their genetics and gene expression.

READ MORE

Blood Tests Offer Early Indicator of Severe COVID-19

News

In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients.

READ MORE

Study of Over 20,000 Individuals Sheds Light on Genetic Contributions to Eating Disorders

News

By analysing the genome of tens of thousands of British people, researchers have discovered similarities between the genetic bases of various eating disorders, and those of other psychiatric disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE